메뉴 건너뛰기




Volumn 25, Issue 10, 2008, Pages 1229-1230

Renal failure and rhabdomyolysis associated with sitagliptin and simvastatin use

Author keywords

Adverse drug event; Renal failure; Sitagliptin

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; BUMETANIDE; CARVEDILOL; CLOPIDOGREL; DIURETIC AGENT; EZETIMIBE; GLIPIZIDE; INSULIN; LEVOTHYROXINE; METOLAZONE; MEVINOLIN; OLMESARTAN; SIMVASTATIN; SITAGLIPTIN;

EID: 53349172746     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2008.02536.x     Document Type: Article
Times cited : (43)

References (5)
  • 1
    • 34447120048 scopus 로고    scopus 로고
    • Effect of renal insufficiency on the pharmacokinetics of sitagliptin, a dipeptidyl peptidase-4 inhibitor
    • Bergman AJ, Cote J, Yi B, Marbury T, Swan SK, Smith W et al. Effect of renal insufficiency on the pharmacokinetics of sitagliptin, a dipeptidyl peptidase-4 inhibitor. Diabetes Care 2007 30 : 1862 1864.
    • (2007) Diabetes Care , vol.30 , pp. 1862-1864
    • Bergman, A.J.1    Cote, J.2    Yi, B.3    Marbury, T.4    Swan, S.K.5    Smith, W.6
  • 2
    • 28844482322 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of single doses of sitagliptin, an inhibitor of dipeptidyl peptidase-IV in healthy subjects
    • Herman GA, Stevens C, Van Dyck K, Bergman A, Yi B, De Smet M et al. Pharmacokinetics and pharmacodynamics of single doses of sitagliptin, an inhibitor of dipeptidyl peptidase-IV in healthy subjects. Clin Pharm Therap 2005 78 : 675 688.
    • (2005) Clin Pharm Therap , vol.78 , pp. 675-688
    • Herman, G.A.1    Stevens, C.2    Van Dyck, K.3    Bergman, A.4    Yi, B.5    De Smet, M.6
  • 3
    • 85061716226 scopus 로고    scopus 로고
    • Washington, DC: Center for Drug Evaluation and Research, Food and Drug Administration, Available at. Last accessed 30 April 2008.
    • Pharmacology/Toxicology Review and Evaluation - NDA 21-995. Washington, DC : Center for Drug Evaluation and Research, Food and Drug Administration, 2006. Available at http://www.accessdata.fda.gov/scripts/cder/drugsatfda Last accessed 30 April 2008.
    • (2006) Pharmacology/Toxicology Review and Evaluation - NDA 21-995.
  • 4
    • 0018645590 scopus 로고
    • An algorithm for the operational assessment of adverse drug reactions: I. Background, description, and instructions for use
    • Kramer MS, Leventhal JM, Hutchinson TA, Feinstein AR. An algorithm for the operational assessment of adverse drug reactions: I. Background, description, and instructions for use. JAMA 1979 242 : 623 632.
    • (1979) JAMA , vol.242 , pp. 623-632
    • Kramer, M.S.1    Leventhal, J.M.2    Hutchinson, T.A.3    Feinstein, A.R.4
  • 5
    • 77950267684 scopus 로고    scopus 로고
    • Center for Drug Evaluation. Research. Center for Drug Evaluation and Research Website. Last accessed 25 October 2007.
    • Center for Drug Evaluation Research. Adverse event reporting system. Center for Drug Evaluation and Research Website. http://www.fda.gov/cder/aers Last accessed 25 October 2007.
    • Adverse Event Reporting System


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.